Fundraising Fox
Micron Biomedical
Atlanta, US · 4 known investors
Find your way into Micron Biomedical
Each arrow is one introduction. Sign up to fill in the first one.
Ask Michael Royals to introduce you to Devin McAllister
You →Michael · together at Micron Biomedical →Devin
Ask Jamie Chen to introduce you to Steve Damon
You →Jamie · together at Durect Corporation →Steve
Sign up to find every way you can get introduced to Micron Biomedical
- Your email: who you already know at Micron Biomedical, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Micron Biomedical team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Micron Biomedical develops dissolvable microarray technology for vaccine and therapeutic delivery as an alternative to traditional injections, targeting expanded global access to treatments across all age groups. The company operates at the clinical stage and is building manufacturing capacity for needle-free pharmaceuticals.
Founders & leadership
Board
Investors · 4
Reported raises · per SEC filings
Form D private placements$32M disclosed across 3 rounds · 2022–2024
▶$15MraisedDec 2024 · 3 investors · BiotechnologyRule 506(b)
- Mark PrausnitzDirector
- Henry SebastienExecutive Officer
- Devin McAllisterExecutive Officer
- Idean MarvastyExecutive Officer
- Brian BernickDirector
- Bas Van BuijtenenDirector
- Steve DamonExecutive Officer, Director
- Matthew GoldmanDirector
- Labeeb AbboudDirector
- Offering amount
- $16.2M
- Amount sold
- $15M
- First sale
- Dec 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3MraisedApr 2023 · 1 investors · BiotechnologyRule 506(b)
- Steve DamonExecutive Officer, Director
- Brian BernickDirector
- Devin McAllisterExecutive Officer
- Mark PrausnitzDirector
- Labeeb AbboudDirector
- Henry SebastienExecutive Officer
- Idean MarvastyExecutive Officer
- Bas Van BuijtenenDirector
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Apr 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$14MraisedDec 2022 · 4 investors · BiotechnologyRule 506(b)
- Idean MarvastyExecutive Officer
- Devin McAllisterExecutive Officer
- Bas van BuijtenenDirector
- Steven DamonExecutive Officer, Director
- Mark PrausnitzDirector
- Sebastien HenryExecutive Officer
- Labeeb AbboudDirector
- Offering amount
- $14M
- Amount sold
- $14M
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Micron Biomedical do?
- Micron Biomedical develops dissolvable microarray technology for vaccine and therapeutic delivery as an alternative to traditional injections, targeting expanded global access to treatments across all age groups. The company operates at the clinical stage and is building manufacturing capacity for needle-free pharmaceuticals.
- Who founded Micron Biomedical?
- Micron Biomedical was founded by Mark Prausnitz.
- Who are Micron Biomedical's investors?
- Micron Biomedical's investors include Global Health Investment Corporation, GRA Venture, J2 Ventures, Global Health Security.
- How much funding has Micron Biomedical raised?
- Micron Biomedical has disclosed $32M raised across 3 rounds.
- Where is Micron Biomedical headquartered?
- Micron Biomedical is headquartered in Atlanta, US.